Current through P.L. 171-2024
Section 16-42-23-4 - Construction of chapter(a) This chapter does not constitute an endorsement of amygdalin (laetrile) for the treatment of a malignancy, a disease, an illness, or a physical condition.(b) This chapter does not prevent a physician from prescribing amygdalin (laetrile) as a dietary supplement to a patient not suffering from a known malignancy, disease, illness, or physical condition upon execution of the written informed request.Pre-1993 Recodification Citation: 16-8-8-4.
As added by P.L. 2-1993, SEC.25.